THERAPY WITH THE HISTONE DEACETYLASE INHIBITOR PRACINOSTAT FOR PATIENTS WITH MYELOFIBROSIS

Approximately half of the patients with myelofibrosis (MF) carry mutant JAK2(V617F) proteins. JAK2(V617F) has been recently shown to translocate to the nucleus and modify specific histones, thus regulating transcription. We report on a phase II study testing the activity and tolerability of the hist...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Quintás-Cardama, Alfonso, Kantarjian, Hagop, Estrov, Zeev, Borthakur, Gautam, Cortes, Jorge, Verstovsek, Srdan
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4152772/
https://ncbi.nlm.nih.gov/pubmed/22475363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.03.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky